22 Jun 2024
// PRESS RELEASE
https://www.takeda.com/newsroom/newsreleases/2024/approval-from-european-commission-for-fruzaqla/
30 Aug 2023
// ONCLIVE
https://www.onclive.com/view/trifluridine-tipiracil-plus-bevacizumab-provides-potential-first-line-alternative-to-bevacizumab-capecitabine-in-mcrc
13 Jun 2023
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214008
13 Oct 2022
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2022/10/13/2534194/35550/en/XBiotech-Announces-First-Patient-Enrolled-into-the-French-National-Cancer-Institute-INCA-Sponsored-Phase-I-II-III-Clinical-Study-for-Natrunix-Therapy-for-Colorectal-Cancer.html
28 Apr 2022
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2022/04/28/2431533/35550/en/XBiotech-Announces-French-National-Agency-ANSM-Approval-and-National-Cancer-Institute-INSA-funding-to-Support-Phase-I-II-III-Clinical-Study-for-Natrunix-in-Combination-with-Triflur.html
23 Nov 2021
// INDIAINFOLINE
https://www.indiainfoline.com/article/news-top-story/natco-pharma-launches-tipanat-tablets-for-advanced-colorectal-gastric-cancer-treatment-in-india-121111800397_1.html